Public trial registry of the CCC-Munich

Trial ABRAZO 673-201

Trial Trial design Status In-/Exclusion Therapy Participants Documents Permissions Tumorboards

Trial
World
Trial acronym
:
ABRAZO 673-201
World
Full title
:

A Phase 2, 2-Stage, 2-Cohort Study of BMN 673 Administered to
Germline BRCA Mutation Subjects with Locally Advanced and/or
Metastatic Breast Cancer

World
Responsible organization
:
Frauenklinik Frauenklinik Ismaninger Str. 22 81675 München Germany Tum
Indications
Classification Code Description
- C50.9 Brustdrüse, nicht näher bezeichnet
Trial design
World
Phase
:
II
Status
World
Status
:
Recruitment finished
Votes
Initiiation & lock
World
Date of lock (planned / actual)
:
Unknown / Unknown
Therapy
World
Therapy
:

Zielgerichtet - Therapieart: palliativ

Participants
Function Prename Surname Organization
World Responsible contact Stefan Paepke Keine Organisationseinheit angegeben Magnifier